Open AccessEfficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis
Author(s) -
P Ravindra Babu,
A. J. S. Pravin,
Gaurav Deshmukh,
Dhiraj Dhoot,
Aniket Samant,
Bhavesh Kotak
Publication year - 2017
Publication title -
indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_191_17
Subject(s) - terbinafine , medicine , adverse effect , potency , lesion , dermatology , surgery , antifungal , biochemistry , chemistry , itraconazole , in vitro
Dermatophytosis are the most common fungal infections globally. Terbinafine is considered to have good potency against dermatophytes, but resistance to terbinafine is on the rise.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom